PMGC Holdings is an early-stage diversified holding company with four wholly owned subsidiaries spanning specialty packaging, precision manufacturing, biotechnology, and investment management. The two revenue-generating businesses were both acquired in July 2025. Pacific Sun Packaging designs and supplies custom protective packaging for sensitive IT hardware components — CPUs, memory modules, SSDs, and fiber-optic transceivers — serving over 300 commercial customers including OEMs, data center operators, and ITAD firms across North America through a direct sales force. AGA Precision Systems is a CNC machine shop that machines high-tolerance components from exotic metals like titanium and Inconel for aerospace, defense, and industrial customers; AGA has historically grown entirely through referrals and repeat business with no formal sales function. The other two subsidiaries are pre-revenue: Northstrive Biosciences is developing engineered probiotic drug candidates (EL-22 and EL-32) designed to preserve muscle mass in patients taking GLP-1 weight-loss drugs; EL-22 has completed Phase 1 safety trials in South Korea but has not yet filed an IND with the FDA, and Northstrive may need a pharma partner to fund further development. PMGC Capital is an internal vehicle focused on direct investments, structured lending, and acquiring undervalued companies. PMGC Holdings' broader strategy centers on acquiring and scaling operating businesses, advancing the biotech pipeline toward an IND filing, and deploying capital through PMGC Capital.